|
| |
ial
| Symbol: | ial | | Name(s): | IplI-aurora-like kinase | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | AurB, CG6620, DmAIRK2, DmAurB, DmAuroraB, IAL1, aurora B | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 16824953 |
INCENP binds to the cohesion protector protein MEI-S332, which is also an excellent in vitro substrate for Aurora B kinase. |
| 12374737 |
Aurora B interacts with and requires the Cdc37/Hsp90 complex for its stability. |
| 12654903 |
This protein accumulates at the mid-zones of chromosome-free spindles. |
Press Releases on ial:
|
 |
| Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer |
28th May, 2009 |
Bayer HealthCare Pharmaceuticals Inc. |
WAYNE, N.J., EMERYVILLE, Calif. and MELVILLE, N.Y., May 28 /PRNewswire-FirstCall/ -- Bayer HealthCare LLC., Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) and
|
| NuVasive Reports First Quarter 2009 Financial Results |
22nd April, 2009 |
NuVasive, Inc. |
Reconciliation of First Quarter 2009 Results
(in thousands, except per share amounts) $ Per Share
GAAP net loss (A)
|
ial results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for ial,
or search for ial on BioPortfolio's antibody search engine.
This page has been viewed 91 times
Recent Search Terms used to find this page: .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
